Name: CytoSiA™ Digital Cytology Platform
Brand: OptraSCAN
Rating: 5 (1 reviews)

Please enter mandatory and valid details

Please fill out the form below and complete all questions with an asterisk (*)

Section 1: Reporter Information

Preferred Method of Contact:
Email Phone Other

Do you wish to remain anonymous?
Yes No

Section 2: Vulnerability Summary

Title / Short Description of Vulnerability

Date Reported to OptraSCAN

How was this vulnerability identified?

Independent research

Customer environment observation

Third-party assessment

Other:

Section 3: Affected Product Information

Please identify the OptraSCAN product(s) or software affected.

Deployment Type:
On-premise Cloud Hybrid Unknown

Section 4: Vulnerability Details

Detailed Description of the Vulnerability

Potential Exploitation Scenario

Impact Assessment (select all that apply)

Patient safety / essential performance

Confidentiality of sensitive data

Integrity of diagnostic results

Availability of system or service

Unauthorized access

Other:

Section 5: Reproduction Details

Steps to Reproduce

Please provide clear steps to reproduce the issue.

Required Preconditions (credentials, settings, access level)

Section 6: Supporting Evidence (Optional)

Please attach or describe any supporting materials.

Screenshots

Logs or system output

Network traces

Proof-of-concept code

Section 7: Severity Estimate (Optional)

Reporter’s suggested severity level:

Critical

High

Medium

Low

Unsure

Justification (if provided):

Section 8: Disclosure and Communication Preferences

Do you request to be credited in any public advisory?

Yes

Anonymous

Have you disclosed this vulnerability to any third party?

Yes

Requested disclosure coordination:

OptraSCAN to coordinate prior to any public disclosure

No preference

Section 9: Reporter Declaration

I agree to the above declaration.